Written and medically reviewed by Dr. Kamen Ng. Last reviewed 2026-11-10. 16 min
By Dr. Kamen Ng · Head of Aesthetic Medicine, AOKLINIK
That sentence is the standard I hold my own work to, and I say it to patients at the first consultation because it sets the brief better than any photograph.
Everybody can tell. The result has to be real. If nobody notices anything, I have taken your money and your afternoon and given you nothing. People should see that you look well.
Nobody knows. They should not be able to say what was done. Not the treatment, not the area, not that anything was done at all. The most common compliment my patients report is about their holiday, their sleep, or their skincare. That is the result working correctly.
Those two halves pull against each other, and the tension between them is the whole discipline. Anybody can produce change. Change is easy, and most of what is wrong in this field is change without restraint. Producing change that cannot be identified is considerably harder, and it is a technical problem rather than a matter of taste.
Why overdone happens
It is worth understanding, because it is almost never what patients assume.
Patients assume overdone faces come from greedy clinics. Sometimes. More often it comes from three mistakes that a careful doctor can make with good intentions.
Chasing the feature instead of reading the face. A patient points at a line and the line gets treated. But the line is frequently a consequence of something else, often somewhere else. Treat the consequence and you need more of it each time, because the cause is untouched. Over several visits that produces a face that has had a lot done to it and does not look better.
The ratchet. Each individual session is modest and reasonable. Nobody reviews the whole, so nothing is ever assessed as a totality, only as an increment. Three years of sensible increments with no step back is how a face drifts without anyone making a decision to change it. This is the single commonest route to an overdone result and it happens almost entirely by accident.
Adaptation. You stop seeing your own face accurately after about the third treatment. So does your doctor, if they are the only one looking. This is why I photograph, and why I compare against two years ago rather than against last month. Your memory of your own face is not a reliable baseline and neither is mine.
The defence against all three is the same, and it is dull: assess the whole face, treat less than you could, photograph, and review before adding.
The constraint I work inside, and why it helps
Everything I use is a registered product or a device registered with the Medical Device Authority under the Medical Device Act 2012. Toxins, fillers, skin-quality injectables, energy-based devices. If it is not registered for use in Malaysia, it is not in my clinic.
Patients sometimes read that as a limitation. It is the opposite, for a reason worth explaining.
A registered product has a dossier behind it. Known rheology, known behaviour in tissue, known duration, known complication profile and known management if something goes wrong. That predictability is precisely what "nobody knows" depends on. An undetectable result requires me to know exactly what a product will do in a specific plane in a specific face, and I cannot know that about something with no published characterisation.
We have treated patients with unbranded product in the past, and the lesson was consistent: the viscosity varied, the behaviour in tissue varied, and the outcome was not reproducible. Unpredictable material cannot produce a controlled result, however good the technique.
There is a second filter I apply. For anything I use regularly, I look at whether the product is available in markets with demanding regulators, Singapore and the European Union among them. It is not a guarantee of anything. It is a reasonable proxy for whether a manufacturer has been willing to put their product in front of people who ask hard questions.
What I do not do is choose a device because its brand name is fashionable, and I have written separately about why the machine's brand is the wrong question for a patient to be asking.
Under the eyes: the problem is light, not volume
This is where the philosophy becomes most literal, because here I am genuinely manipulating optics.
Patients come in asking for filler for their dark circles. Often they do not need filler, and sometimes filler would make them worse. The conversation starts by working out what is actually making the area dark, because there are four different causes and they do not respond to the same thing.
A true shadow. The hollow of the tear trough is a concavity. Light arriving from above casts a shadow into it, exactly as it would into any depression. The skin there may be a perfectly normal colour. What you are seeing is not pigment, it is geometry.
Vascular show-through. The skin of the lower lid is the thinnest on the body. Underlying muscle and vessels read through it as a bluish or purplish tone. Nothing is wrong with the surface; you are seeing what is beneath it.
Pigmentation. Genuine periorbital hyperpigmentation, common in our patient population, often familial, sometimes post-inflammatory from rubbing or eczema. This is melanin in the skin itself.
Skin quality. Crepe texture and fine laxity, which scatter light and dull the area regardless of what lies underneath.
Filler addresses the first one. Only the first one.
If I place product in the hollow, the concavity flattens, light no longer falls into a depression, and the shadow goes. The skin colour has not changed by one shade. I have changed the shape of the surface so that light meets it differently.
And if the cause is pigment, filler does nothing. Product under pigmented skin leaves pigmented skin, now with product under it. Patients who have had this done elsewhere and seen no improvement usually had the wrong one of the four.
The cautionary inverse
The same optical principle that makes this work is also how it goes wrong.
HA placed too superficially in the lower lid scatters short-wavelength light and appears as a bluish-grey discolouration through the skin. This is the Tyndall effect, and it is the exact failure mode of the thing I am describing: an attempt to improve how light falls that instead creates a new optical problem, in a very visible place, that will persist as long as the product does.
It is avoided by placing deep, against bone, in small volumes, with a product chosen for the purpose rather than whatever is open on the tray.
The other risks here are real and worth naming. The lower lid and midface carry vessels where a vascular event has serious consequences, which is why I use a reversible product in this region and nothing else. And product that draws water, or placement that sits over the orbital rim, can produce persistent puffiness that patients find worse than the shadow they came in about. Our complications article sets out how these are managed.
Why the answer is often somewhere else
Here is the part that surprises patients most. The tear trough is frequently a consequence of lost support above and lateral to it, not a problem of its own.
When the midface loses its underlying support, the tissue descends slightly and the trough deepens as a result. Restore support at the cheek and the orbital rim, and the trough improves without anything being placed in the lid at all.
That is a better treatment. Less product, in a safer plane, further from the thin skin, addressing the cause rather than the appearance. A fair number of patients who ask me for under-eye filler leave having had none, and looking better for it.
When I do treat the trough directly, the volumes are small. A tenth of a millilitre matters here in a way it does not anywhere else on the face.
The AO Crown Lift
This is among the most requested treatments we do, and it is the clearest example of getting a lift without anything in the face looking altered.
What it is. Botulinum toxin, not filler. Nothing is added to the face at all, which is why it belongs in this article more than anything else I do.
Why that produces a lift. The brow is governed by a tug of war, and most patients have never been told this.
The frontalis is the only muscle that lifts the brow. It has no help. Working against it are four muscles that pull the brow down: the procerus, corrugator supercilii and depressor supercilii pull the medial brow down, and the orbicularis oculi pulls the lateral brow down.
So the brow sits wherever that contest settles. Weaken the muscles pulling down, leave the one pulling up intact, and the brow rises on its own. I have not lifted anything. I have taken the brakes off.
For the lateral brow and the hooding above the outer eye, the relevant target is the orbicularis just outside the orbital rim, in very small amounts, placed superficially.
Why it reads as undetectable. There is no volume anywhere, so there is nothing to look full, nothing to feel, and nothing that can be seen in profile. The eye opens slightly, the brow sits a little higher, the hood above the outer eye lightens. Patients get told they look rested. Nobody looks at a brow position and concludes a treatment happened, because brow position is not a thing people have a memory of.
Why restraint is not optional here, it is the mechanism. This is the part I want patients to understand, because it explains a result they may have seen on someone else and disliked.
If you treat the frontalis too heavily, or too low, you weaken the only muscle lifting the brow. The brow comes down. That is the heavy, flat, slightly sad upper face that people recognise as having had something done, and it is the exact opposite of a lift, produced by treating the same region with the same product.
So the whole technique is an exercise in judgement about how much to leave alone. Treating the forehead lines hard and ignoring the depressors trades your lines for a heavy brow. Treating the depressors precisely and the frontalis lightly gives you a lift. Same product, same area, opposite outcomes, and the difference is restraint rather than skill with a needle.
I assess and record brow and lid position before injecting, every time, because someone with an already low brow or a degree of lid ptosis is a different proposition, and in those patients the risk is making it worse.
What I mean by predictable, since patients repeat this word back to me. I mean reproducible, because the anatomy is consistent and the mechanism is a known contest between named muscles rather than a hope about tissue behaviour. I do not mean guaranteed. The degree of lift depends on your starting brow position, how strong your depressors are, and how much genuine skin redundancy you have. Someone whose brow is held down by active depressors does well. Someone whose upper lid is heavy with loose skin will get less, and the honest version of that conversation belongs at the assessment rather than afterwards.
And it wears off, which for a first-time patient is a feature rather than a drawback. If the result is not what you wanted, it resolves. I would far rather introduce someone to the idea of a lifted brow with something temporary than with anything that cannot be undone.
Cross-linked and skin-quality HA do different jobs
Patients often think of hyaluronic acid as one thing. It is a category, and the products within it are asked to do opposite things.
Cross-linked HA is architecture. The HA chains are bonded to one another, which makes the gel resist breakdown and hold its shape under the pressure of surrounding tissue. That is what you want from something supporting a structure. Its firmness and cohesivity decide where it belongs: a firm gel on bone for support, a softer one in mobile tissue where it needs to integrate rather than hold.
Skin-quality HA is tissue, not shape. These products are placed in the skin to improve its quality: hydration, surface texture, light reflectance, fine crepe. They are not there to support anything, and asking them to is a misuse. Some are lightly cross-linked, some are stabilised by other means, and the category is defined by the job and the placement depth rather than by one chemistry. The proposed mechanism is a combination of hydration and mechanical stimulation of fibroblasts, with reported increases in collagen and elastin.
Free, unstabilised HA is broken down within a day or two. It hydrates briefly and does little else, which is why durable skin-quality products are stabilised in some fashion.
Why I use both in one plan
Because they solve different halves of the same complaint, and this is where "everybody can tell, nobody knows" is actually won.
A patient in her forties says she looks tired. Reading her face, two things are true. She has lost structural support, which is a shape problem. And her skin has lost quality: duller, drier, finer lines, light falling flat on it.
Treat only the structure and the shape is better but the skin still looks tired, and there is a limit to how much support you can add before it stops looking like her. Treat only the skin and it glows, on a face that has lost its framework.
Layering both means less of each. That is the real argument. I do not need to push structure to its limit to compensate for skin I have not addressed, and the skin work makes a modest amount of structural support look like more than it is, because good skin reflects light better.
The economy of it is the point. Doing two things gently beats doing one thing hard, and it is far less likely to be noticed.
The same restraint, applied to toxin and devices
Toxin. The dose decides whether you look rested or frozen, and the usual error is treating a muscle as something to eliminate rather than to weaken. Expression should survive. For a first-time patient I dose low and review at two weeks, because adding is easy and waiting out too much is three or four months of looking like someone else. Men generally need more than women, which I have covered elsewhere, and that is a dosing judgement rather than a rule.
Energy-based devices. Device selection is my job rather than yours, in the same way the choice of implant is a surgeon's. What matters for a patient in Malaysian skin is not the brand on the handpiece but the settings and the intervals, because in Fitzpatrick IV and V the governing risk is post-inflammatory hyperpigmentation, and that comes from being too aggressive rather than from using the wrong machine. Conservative settings across more sessions produce a better result here than one heroic treatment, and the patients who come to me with pigmentation after treatment elsewhere were almost always treated too hard once.
How I actually keep it undetectable
Four habits. None of them is clever.
Under-treat the first session, deliberately. I plan for a review. A patient who leaves slightly undercooked and comes back in three weeks ends up in a better place than one who leaves fully corrected, because I have seen the tissue respond before committing to the rest.
Photograph, in the same light. Against two years ago, not last month. Drift is invisible month to month and obvious across years.
Treat the cause, not the complaint. The complaint tells me where to look. It does not usually tell me where to inject.
Be willing to say no. The most useful thing I do some days is decline. If what you are asking for would not suit your face, or would need a volume of change that becomes visible, or belongs with a surgeon, saying so is the service. I have had patients go elsewhere and have it done, and a few have come back. That is a reasonable cost.
The short version
Everybody can tell. Nobody knows. The result must be real and it must be unidentifiable, and holding both at once is the technical problem of this work.
Overdone faces usually come from treating features instead of reading the face, from years of reasonable increments that nobody ever reviews as a whole, and from everyone involved losing their baseline.
Under the eyes, the problem is often light rather than volume. Dark circles have four separate causes, filler addresses one of them, and placing it too superficially creates the opposite optical problem. The answer is frequently support in the midface instead.
The AO Crown Lift uses toxin rather than filler. The frontalis is the only muscle lifting the brow and four muscles pull it down, so weakening the depressors and leaving the elevator alone lets the brow rise on its own. Nothing is added, which is why it is undetectable. Treat the frontalis too hard and you get the opposite, a heavy brow, from the same product in the same area.
Cross-linked HA is architecture. Skin-quality HA is tissue. Using both means less of each, and less of each is how a result stays undetectable.
Everything used is registered for use in Malaysia, because an undetectable result depends on knowing exactly how a material behaves.
Book a consultation
If you have been put off by results you have seen on other people, that is a reasonable place to start a conversation. Bring photographs of what you do not want as readily as what you do.
Book a consultation with Dr. Kamen Ng at AOKLINIK Penang.
References
- Applied anatomy for botulinum toxin injection in cosmetic interventions. Current Otorhinolaryngology Reports. 2020 link.springer.com
- Eyebrow elevation using chemomodulation and myomodulation: a cohort analysis pmc.ncbi.nlm.nih.gov
- The impact of botulinum toxin on brow height and morphology: a randomised controlled trial researchgate.net
- Hybrid cooperative complexes of high and low molecular weight hyaluronans: review of the literature researchgate.net
- Hyaluronic acid hybrid cooperative complexes, update on safety assessment from post-marketing surveillance ncbi.nlm.nih.gov
- An overview of soft tissue fillers for cosmetic use dovepress.com
- Medical Device Authority, Malaysia. Medical device registration under the Medical Device Act 2012 mmdr.mda.gov.my
Frequently asked questions
No. Often I do more things, each more gently, which is a different strategy from doing one thing aggressively. Layering structure with skin quality, as above, usually means a longer plan and less product in any single place.
You see it, in photographs, and in the mirror once the swelling settles. What other people register is that you look well rather than that you look different. If you want a change that people remark on specifically, I am honestly not the right doctor for that, and it is better established at the consultation than afterwards.
It depends which of the four causes you have. If it is a true shadow from the hollow, usually yes. If it is pigment, no, and anyone promising otherwise is selling. Often the better answer is support in the midface rather than product in the lid.
No. A surgical brow lift removes and repositions tissue, and the result is larger and lasts far longer. The AO Crown Lift uses toxin to weaken the muscles that pull the brow down, so your own elevator muscle raises it. The ceiling is lower, the commitment is far lower, it wears off, and it does nothing for genuinely redundant skin.
No, and the distinction matters. Treating the forehead to soften lines means weakening the frontalis, which is the muscle holding your brow up. Done without attention to the depressors, that lowers the brow. The AO Crown Lift targets the depressors instead and treats the frontalis with restraint, which is close to the opposite approach. If you have had forehead treatment before and felt heavy afterwards, that is the distinction you were feeling.
It varies by product, area and individual metabolism, and I will give you a range for your specific plan rather than a number here. What I would say is that the aim is to maintain rather than to let everything go and rebuild, because maintaining takes less product.
I would rather not, and the reason is the review. Foundation, then assess at the point where I can see the true result rather than the swollen version, then refine if it is needed. It frequently turns out that less is needed than we planned.
We will discuss it honestly. Sometimes I am being too conservative and the patient is right. Sometimes we disagree and I decline. Either way you will know where I stand rather than find out through the result.